Accolades
Sidley Named “Belgium Firm of the Year” at LMG Life Sciences EMEA Awards 2024
May 20, 2024
Sidley has been named “Belgium Firm of the Year” at the LMG Life Sciences EMEA Awards 2024. The awards bring together Europe’s legal community to celebrate the success and accomplishments of leading law firms and individuals behind the most innovative and challenging work in the life sciences industry.
Sidley’s European Life Sciences practice provides comprehensive EU, Swiss, German, and UK regulatory, litigation, and transactional support for a broad range of life sciences companies, including biopharma, medical devices, animal health, food technology, software, consumer products, and platform services to the industry. The team advises on cutting-edge regulatory, compliance, and competition issues for established and emerging life sciences companies, as well as acting on cases with wide-ranging regulatory implications before national and European courts.
Sidley’s European Life Sciences practice provides comprehensive EU, Swiss, German, and UK regulatory, litigation, and transactional support for a broad range of life sciences companies, including biopharma, medical devices, animal health, food technology, software, consumer products, and platform services to the industry. The team advises on cutting-edge regulatory, compliance, and competition issues for established and emerging life sciences companies, as well as acting on cases with wide-ranging regulatory implications before national and European courts.
Offices
Capabilities
Suggested News & Insights
BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025Sidley Ranked in Chambers Asia-Pacific 2026December 11, 2025U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 11, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025Sidley Represents Capricor Therapeutics in US$172.5 Million Common Stock OfferingDecember 10, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory